Fumaric Acid

Fumaric Acid

SCHEMBL6590452

COc1cc(N)c(I)cc1C(=O)NC1CCN(C(C(=O)N2CCCC2)C2CCNCC2)CC1.O=C(O)C=CC(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 known ✓ Q13639 7/20 0.47
ADRA2A known ✓ P08913 1/20 0.40
DRD2 known ✓ P14416 1/20 0.40
ADRA2B known ✓ P18089 1/20 0.40
ADRA2C known ✓ P18825 1/20 0.40
SLC6A2 known ✓ P23975 1/20 0.40
HTR2A known ✓ P28223 1/20 0.40
HTR2C known ✓ P28335 1/20 0.40
ADRA1A known ✓ P35348 1/20 0.40
HTR2B known ✓ P41595 1/20 0.40
SLC6A3 known ✓ Q01959 1/20 0.40
KCNH2 known ✓ Q12809 1/20 0.40
CYP3A4 P08684 2/20 0.46
ACHE P22303 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6586298 0.91 HTR4 (0.47) HTR4CYP3A4ACHECYP1A2ADRA2A
Fumaric Acid SCHEMBL6588045 0.88 HTR4 (0.48) HTR4CYP3A4ACHECYP1A2ADRA2A
SCHEMBL6586470 0.86 HTR4 (0.52) HTR4CYP3A4ACHECYP1A2ADRA2A
SCHEMBL6584473 0.86 HTR4 (0.67) HTR4CYP3A4ACHECYP1A2ADRA2A
SCHEMBL6588610 0.85 HTR4 (0.66) HTR4CYP3A4ACHECYP1A2ADRA2A
Fumaric Acid SCHEMBL6590852 0.80 HTR4 (0.49) HTR4CYP3A4ACHECYP1A2ADRA2A
Fumaric Acid SCHEMBL6588346 0.79 HTR4 (0.61) HTR4CYP3A4ACHECYP1A2ADRA2A
Fumaric Acid SCHEMBL6580490 0.77 HTR4 (0.56) HTR4CYP3A4ACHECYP1A2ADRA2A
Maleic Acid SCHEMBL7260321 0.77 HTR4 (0.56) HTR4CYP3A4ACHECYP1A2ADRA2A
Fumaric Acid SCHEMBL7264897 0.77 HTR4 (0.56) HTR4CYP3A4ACHECYP1A2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1076055-B1 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS DAINIPPON PHARMACEUTICAL CO (JP) 2004-11-24 EP disclosed
US-6294555-B1 SEROTONIN HT3 RECEPTOR ANTAGONIST FOR GASTROINTESTINAL DISORDERS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2001-09-25 US disclosed
EP-1076055-A1 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS Dainippon Pharmaceutical Co., Ltd. (JP) 2001-02-14 EP disclosed